|
|
A Circulating Biomarker for use in Monitoring Metastatic Breast Cancer
|
1R43CA210817-01A1
|
$152,589
|
$152,589
|
SERRERO, GINETTE
|
A AND G PHARMACEUTICAL, INC.
|
|
|
Antibody targeting of ADAM8 for treatment of triple-negative breast cancer
|
3R41CA200161-01A1S2
|
$50,000
|
$50,000
|
SONENSHEIN, GAIL
|
ADECTO PHARMACEUTICALS, INC.
|
|
|
Integrin Regulation of Cancer Progression Through Alternative mRNA Splicing and Nonsense-Medidated Decay (NMD)
|
5R01CA129637-07
|
$375,250
|
$375,250
|
DIPERSIO, C. MICHAEL
|
ALBANY MEDICAL COLLEGE
|
|
|
(7) Novel imaging devices for measurement and control of tumor microenvironments
|
1R01CA216248-01
|
$565,675
|
$565,675
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
MOTILITY AND INVASION
|
5P01CA100324-15
|
$2,028,990
|
$2,028,990
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Signal transduction regulating tumor cell dissemination
|
5R01CA150344-29
|
$396,625
|
$396,625
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Core Support for Cancer Center
|
3P30CA013330-44S1
|
$199,871
|
$35,977
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Core Support for Cancer Center
|
3P30CA013330-44S2
|
$199,989
|
$35,998
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Core Support for Cancer Center
|
3P30CA013330-44S3
|
$500,000
|
$90,000
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Core Support for Cancer Center
|
5P30CA013330-45
|
$3,646,138
|
$1,312,610
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
The role of tunneling nanotubes as a novel mode of tumor cell-macrophage communication
|
5F99CA212451-02
|
$44,044
|
$44,044
|
HANNA, SAMER
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Roles of formins in breast cancer invasion
|
5R21CA205262-02
|
$217,935
|
$217,935
|
HODGSON, LOUIS
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Inhibition of Senescence to Increase Cancer Cell Death: A New Paradigm
|
5R01CA077263-18
|
$417,500
|
$137,775
|
MCDAID, HAYLEY
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
The Metastatic Cascade: Macrophages Lead the Way
|
5R01CA172451-06
|
$439,400
|
$145,002
|
POLLARD, JEFFREY
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Molecular markers of risk of subsequent invasive breast cancer in women wth ductal carcinoma in situ
|
1R01CA218429-01
|
$1,513,571
|
$1,513,571
|
ROHAN, THOMAS
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
The B7x pathway in the tumor microenvironment
|
5R01CA175495-05
|
$346,525
|
$69,305
|
ZANG, XINGXING
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
A NOVEL SMALL MOLECULE CX3CR1 ANTAGONIST HALTS METASTASIS
|
2R44CA183362-02A1
|
$822,075
|
$411,038
|
SALVINO, JOSEPH
|
ALLIANCE DISCOVERY, INC.
|
|
|
Immunosignatures to Distinguish Breast Cancer Subtypes and Cancer Recurrence
|
1R21CA220150-01
|
$123,600
|
$123,600
|
JOHNSTON, STEPHEN
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Novel approaches to study immune responses to post translational modifications for cancer detection
|
5U01CA214201-02
|
$462,286
|
$231,143
|
LABAER, JOSHUA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Couple Communication in Cancer: A Multi-Method Examination
|
5R01CA201179-02
|
$650,269
|
$325,135
|
LANGER, SHELBY
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Effects of Meditative Movement (Qigong/Tai Chi Easy) on Fatigued Breast Cancer Survivors
|
3R01CA182901-03S1
|
$129,167
|
$129,167
|
LARKEY, LINDA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Effects of Meditative Movement (Qigong/Tai Chi Easy) on Fatigued Breast Cancer Survivors
|
5R01CA182901-03
|
$597,280
|
$597,280
|
LARKEY, LINDA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Proteasome inhibitors for the treatment of solid tumors
|
1R01CA213223-01A1
|
$381,450
|
$381,450
|
KISSELEV, ALEXEI
|
AUBURN UNIVERSITY AT AUBURN
|
|
|
Interferon-gamma limits the effectiveness of peptide vaccines for cancer
|
5R01CA157303-06
|
$294,616
|
$73,654
|
CELIS, ESTEBAN
|
AUGUSTA UNIVERSITY
|
|
|
DACH1/Eya Cell fate determination factor and mammary tumorigenesis
|
7R01CA132115-08
|
$428,056
|
$428,056
|
PESTELL, RICHARD
|
BARUCH S. BLUMBERG INSTITUTE
|
|
|
PNNL Proteome Characterization Center
|
5U24CA210955-02
|
$1,091,415
|
$360,167
|
LIU, TAO
|
BATTELLE PACIFIC NORTHWEST LABORATORIES
|
|
|
Risk Prediction for ER Negative Breast Cancer Recurrence
|
5R01CA172511-05
|
$593,132
|
$593,132
|
BONDY, MELISSA
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Investigating the mechanisms of CD44s splice isoform in breast cancer metastasis
|
5R01CA182467-05
|
$328,888
|
$328,888
|
CHENG, CHONGHUI
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Role of Sympathetic Activation and RANKL/IL6 in Breast Cancer Bone Metastasis
|
5R01CA168717-05
|
$323,700
|
$323,700
|
ELEFTERIOU, FLORENT
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
MICROSCALED PROTEOGENOMICS FOR CANCER CLINICAL TRIALS
|
1U01CA214125-01
|
$1,452,478
|
$1,452,478
|
ELLIS, MATTHEW
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
MECHANISMS OF AR-ER COLLABORATION IN HORMONE RESISTANCE AND METASTASIS OF BREAST CANCER
|
1R01CA207270-01A1
|
$362,569
|
$362,569
|
FUQUA, SUZANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Integration of Predictive Biomarkers of Hormone Resistance in Breast Cancer
|
5R01CA072038-19
|
$320,963
|
$320,963
|
FUQUA, SUZANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Epigenomic reprogramming driven by mutant ER? in metastatic breast cancer
|
5F31CA210385-02
|
$43,993
|
$43,993
|
GATES, LEAH
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Mitochondrial DNA copy number and fat metabolism in triple negative breast cancer
|
1R03CA212816-01
|
$79,250
|
$79,250
|
KAIPPARETTU, BENNY
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
A Novel LGR4 Oncogenic Signaling in Breast Cancer Progression and Metastasis
|
1R01CA204926-01A1
|
$362,569
|
$362,569
|
LI, YI
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Ruxolitinib for Preventing Breast Cancer in Women on Neuroleptics
|
1R01CA205594-01A1
|
$362,569
|
$362,569
|
LI, YI
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
The cell of origin of breast cancer metastasis
|
5R21CA202227-02
|
$206,843
|
$206,843
|
LI, YI
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Novel therapeutics for targeting checkpoint dysfunction in cancer
|
1R01CA203824-01A1
|
$362,569
|
$271,927
|
LIN, WEEI-CHIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
New mechanisms of breast cancer metastasis and loss of estrogen receptor driven by 14-3-3
|
5R21CA198041-02
|
$172,369
|
$172,369
|
LIN, WEEI-CHIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Translational control of EMT by the CELF1 RNA Binding Protein
|
5R01CA190467-03
|
$362,569
|
$362,569
|
NEILSON, JOEL
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S1
|
$118,016
|
$27,144
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S2
|
$170,897
|
$39,306
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S3
|
$118,875
|
$27,341
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S4
|
$499,947
|
$114,988
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S5
|
$134,220
|
$30,871
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S1
|
$118,333
|
$30,767
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S2
|
$118,875
|
$30,908
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S3
|
$122,250
|
$31,785
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S4
|
$250,002
|
$65,001
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-11
|
$3,253,119
|
$845,811
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Total relevant funding to Breast for this search: $570,072,752
|
